Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR study

Autor: X Salgado, Covadonga Torres, Antonio Ocampo, Evelyn Martinez, M. Rodriguez, Pere Domingo, Miguel Yzusqui, J Diz, Daniel Podzamczer, A. Muñoz, M A Sepúlveda, A Bahamonde, J F Lorenzo, A Casado, Nerea Rozas, José E. P. Santos, M I Mayorga, J R Barberá, Pablo Bachiller, P. Fernandez

Publikováno v: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Objectives: To analyse lipid changes and tolerability in a cohort of HIV-infected patients who switched their anti- retroviral regimens to rilpivirine/emtricitabine/tenofovir (RPV/FTC/TDF) in a real-world setting. Methods: PRO-STR is a 48 week prospe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2758d941964884203d036dfc3369d483
https://doi.org/10.1093/jac/dky175

Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial

Autor: Marta Valle, Cristina Miranda, Maria Gracia Mateo, Maria del Mar Gutierrez, Daniel Podzamczer, Nerea Rozas, María Silvana DiYacovo, María Silvana Di Yacovo, José Moltó, Jordi Navarro, Eugenia Negredo, Gracia Mateo, Guillem Sirera, Núria Pérez-Álvarez, Adrian Curran, Antonia Vila, Beatriz Mothe, José R. Santos, Josep Coll, Esteban Ribera, Joaquin Burgos, Josep M. Llibre, Elena Ferrer, Bonaventura Clotet, Silvia Gel, Pere Domingo

Publikováno v: RIUVic. Repositorio Institucional de la Universidad de Vic
instname

Objectives Maximizing ART efficiency is of growing interest. This study assessed the efficacy, safety, pharmacokinetics and economics of a darunavir dose-reduction strategy. Methods This was a multicentre, randomized, open-label clinical trial in HIV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f78b5701087cf274c9d1a978c88abaae
https://doi.org/10.1093/jac/dku516

Elvitegravir concentrations in seminal plasma in HIV-1-infected men

Autor: Antonia Vila, Arkaitz Imaz, Laura Acerete, Angela D. M. Kashuba, Craig Sykes, Nerea Rozas, Jordi Niubó, E. Ferrer, Daniel Podzamczer

Publikováno v: HIV medicine. 18(3)

Objectives The aim of the study was to quantify elvitegravir (EVG) concentrations in the semen of HIV-1-infected men receiving antiretroviral therapy (ART) consisting of an elvitegravir/cobicistat/emtricitabine/tenofovir (EVG/COBI/FTC/TDF) single-tab

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72ad84d68f17ece4820611ec36f032c0
https://pubmed.ncbi.nlm.nih.gov/27477062

CSF LPV concentrations and viral load in viral suppressed patients on LPV/r monotherapy given once daily

Autor: Daniel Podzamczer, Arkaitz Imaz, Maria Saumoy, Jordi Niubó, Juan Tiraboschi, Marga Maso, Nerea Rozas, Antonia Vila, Elena Ferrer

Publikováno v: Journal of the International AIDS Society
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona

Introduction : Plasma trough concentrations of lopinavir (LPV) given as LPV/r 800/200 mg once daily (OD) are reduced in comparison with 400/100 mg twice daily (BID). While OD dosage of LPV/r is sufficient to achieve viral suppression in plasma, data

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58dc349ce1bd05ab08520fda44c1ee67
https://pubmed.ncbi.nlm.nih.gov/25394093

Long-term fat redistribution in ARV-naïve HIV+ patients initiating a non-thymidine containing regimen in clinical practice

Autor: Daniel Podzamczer, Jordi Curto, Maria Saumoy, Juan Tiraboschi, Nerea Rozas, Carmen Gómez, Antonio Navarro, Elena Ferrer, Gladys Barrera, Pilar Medina

Publikováno v: Journal of the International AIDS Society
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona

Introduction : Lipodystrophy is still a matter of concern in HIV+ patients receiving ART. However, long-term fat change in patients taking non-thymidine regimens is not well known. Materials and Methods : A prospective ongoing fat change assessment i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5d654c6edcb29f8dd08cf3e64884078
http://europepmc.org/articles/PMC4224890